Gomez CM - Search Results

1

A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome.

Gomez CM, Maselli R, Gammack J, Lasalde J, Tamamizu S, Cornblath DR, Lehar M, McNamee M, Kuncl RW. Gomez CM, et al. Ann Neurol. 1996 Jun;39(6):712-23. doi: 10.1002/ana.410390607. Ann Neurol. 1996. PMID: 8651643

2

A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome.

Gomez CM, Gammack JT. Gomez CM, et al. Neurology. 1995 May;45(5):982-5. doi: 10.1212/wnl.45.5.982. Neurology. 1995. PMID: 7538206

3

Effector mechanisms of myasthenic antibodies.

Richman DP, Wollmann RL, Maselli RA, Gomez CM, Corey AL, Agius MA, Fairclough RH. Richman DP, et al. Among authors: gomez cm. Ann N Y Acad Sci. 1993 Jun 21;681:264-73. doi: 10.1111/j.1749-6632.1993.tb22891.x. Ann N Y Acad Sci. 1993. PMID: 8357166 No abstract available.

4

A transgenic mouse model of the slow-channel syndrome.

Gomez CM, Bhattacharyya BB, Charnet P, Day JW, Labarca C, Wollmann RL, Lambert EH. Gomez CM, et al. Muscle Nerve. 1996 Jan;19(1):79-87. doi: 10.1002/(SICI)1097-4598(199601)19:1<79::AID-MUS11>3.0.CO;2-Z. Muscle Nerve. 1996. PMID: 8538674

5

Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.

Gomez CM, Maselli R, Gundeck JE, Chao M, Day JW, Tamamizu S, Lasalde JA, McNamee M, Wollmann RL. Gomez CM, et al. J Neurosci. 1997 Jun 1;17(11):4170-9. doi: 10.1523/JNEUROSCI.17-11-04170.1997. J Neurosci. 1997. PMID: 9151734 Free PMC article.

6

Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents.

Bhattacharyya BJ, Day JW, Gundeck JE, Leonard S, Wollmann RL, Gomez CM. Bhattacharyya BJ, et al. Among authors: gomez cm. Synapse. 1997 Dec;27(4):367-77. doi: 10.1002/(SICI)1098-2396(199712)27:4<367::AID-SYN10>3.0.CO;2-P. Synapse. 1997. PMID: 9372559

7

Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset.

Gomez CM, Thompson RM, Gammack JT, Perlman SL, Dobyns WB, Truwit CL, Zee DS, Clark HB, Anderson JH. Gomez CM, et al. Ann Neurol. 1997 Dec;42(6):933-50. doi: 10.1002/ana.410420616. Ann Neurol. 1997. PMID: 9403487

8

Genetic manipulation of AChR responses suggests multiple causes of weakness in slow-channel syndrome.

Gomez CM, Maselli R, Williams JM, Bhattacharyya BB, Wollmann RL, Day JW. Gomez CM, et al. Ann N Y Acad Sci. 1998 May 13;841:167-80. doi: 10.1111/j.1749-6632.1998.tb10923.x. Ann N Y Acad Sci. 1998. PMID: 9668235 No abstract available.

9

Antibody effector mechanisms in myasthenia gravis. The complement hypothesis.

Richman DP, Agius MA, Kirvan CA, Gomez CM, Fairclough RH, Dupont BL, Maselli RA. Richman DP, et al. Among authors: gomez cm. Ann N Y Acad Sci. 1998 May 13;841:450-65. doi: 10.1111/j.1749-6632.1998.tb10962.x. Ann N Y Acad Sci. 1998. PMID: 9668274 Review. No abstract available.

10

Presynaptic congenital myasthenic syndrome due to quantal release deficiency.

Maselli RA, Kong DZ, Bowe CM, McDonald CM, Ellis WG, Agius MA, Gomez CM, Richman DP, Wollmann RL. Maselli RA, et al. Among authors: gomez cm. Neurology. 2001 Jul 24;57(2):279-89. doi: 10.1212/wnl.57.2.279. Neurology. 2001. PMID: 11468313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters